semaglutide blindness study The popularity of GLP-1 agonists (Ozempic, Wegovy, Semaglutide) is unmatched, but we are just beginning to see the catastrophic eye complications. I recently saw a healthy woman in her early 40s with Ophthalmic complications with semaglutide and

January 2026: Amgen completed Phase 3 enrollment for MariTide (AMG 133) in the MARITIME-Obesity trial, with interim efficacy data expected in Q3 2026 that will position the monthly injection GLP-1/GIP antagonist as a once-monthly obesity treatment alternative

Antiviral defense systems in the rumen microbiome

The new research raises hope that GLP-1 drugs could serve as a strategy for breast cancer prevention, especially among higher-risk females with overweight and obesity

Semaglutide Regarding adverse events, both Tirzepatide and Semaglutide demonstrated comparable safety profiles, with GI events being the most frequently reported

In the SURMOUNT trials, tirzepatide at its highest dose produced average weight loss of roughly 20-22%